Berkane N, Nizard J, Dreux B, Uzan S, Girot R
Service de Gynécologie-Obstétrique et Médecine de la Reproduction, Hôpital Tenon, Paris, France.
Pathol Biol (Paris). 1999 Jan;47(1):46-54.
An increasing number of sickle cell disease patients are deciding to bear children. The high risk of fetal and maternal complications in pregnant sickle cell disease patients mandates multidisciplinary management. Risks include spontaneous abortion, vasculorenal syndrome, fetal growth retardation, and fetal death in utero. The rates of cesarean section, maternofetal infection, and maternal death are higher than in the population at large. The diagnosis should be made prior to conception or during early pregnancy. Frequent visits with the obstetrician, hematologist, and anesthesiologist/intensivist are mandatory. Exchange transfusion or blood transfusion may be indicated in patients with a history of serious obstetrical or hematologic complications. Risks are highest in late pregnancy, during delivery, and in the postpartal period. However, the entire pregnancy is a high-risk period that warrants close monitoring.
越来越多的镰状细胞病患者决定生育。患有镰状细胞病的孕妇出现胎儿和母体并发症的风险很高,这就需要多学科管理。风险包括自然流产、血管肾综合征、胎儿生长受限和子宫内胎儿死亡。剖宫产、母婴感染和产妇死亡的发生率高于普通人群。诊断应在受孕前或孕早期进行。必须经常与产科医生、血液科医生和麻醉师/重症监护医生会诊。有严重产科或血液学并发症病史的患者可能需要进行换血或输血。妊娠晚期、分娩期间和产后风险最高。然而,整个孕期都是高危期,需要密切监测。